Give me a brief information for leptospirosis

Reading File

Finding Sources

Searching Images

leptospirosis clinical findings spirochete

Searching PubMed

leptospirosis

Reading File

Here is a concise overview of leptospirosis drawn from authoritative medical textbooks:

Leptospirosis

Definition & Causative Agent

Leptospirosis is a zoonotic bacterial infection caused by pathogenic spirochetes of the genus Leptospira - thin, highly motile, coiled organisms measuring 0.1 µm in diameter and 6-20 µm in length. The most clinically important species is Leptospira interrogans, named for its question-mark shape. Over 25 serogroups and 250 serovars exist, differing by geography and host specificity.

Goldman-Cecil Medicine, p. 2416

Epidemiology

The most widespread zoonosis globally, causing ~1 million clinical infections and ~60,000 deaths per year
Most prevalent in tropical, humid, rural environments (India, Malaysia, Brazil, Philippines, Thailand)
Primarily a disease of poverty - spikes during flooding when rodents are displaced
Affects farmers, sewage workers, miners, veterinarians, and adventure travellers
Reservoir hosts: rodents (especially Rattus norvegicus), cattle, dogs - they shed leptospires in urine into soil and water
Climate change is expected to increase incidence due to more frequent extreme rainfall events
Goldman-Cecil Medicine, p. 2426-2432

Transmission

Humans acquire infection through:

Direct or indirect contact with infected animal urine
Skin abrasions, conjunctiva, or upper alimentary mucosa (not intact skin)
Contaminated soil or floodwater
Human-to-human transmission is rare

Pathogenesis

The organism enters through mucous membranes or skin breaks, spreads via bacteremia to all organs including the CNS and kidneys. Key targets are the renal tubules (causing interstitial nephritis) and vascular endothelium. The second (immune) phase of illness is partly antibody-mediated. Antibodies clear bacteremia but also drive immune-mediated tissue damage.

Sherris & Ryan's Medical Microbiology, p. 1424

Clinical Features

Incubation period: 5-14 days (typically 7-13 days)

About 90% of infections are subclinical. Clinical illness has two phases:

Phase 1 - Leptospiremic (days 1-7):

Abrupt-onset fever, chills, severe headache
Myalgia (especially calf muscles)
Conjunctival suffusion (redness without discharge - a characteristic sign)
Leptospires detectable in blood and CSF

Phase 2 - Immune phase (week 2 onward):

Fever may recur after brief remission
Aseptic meningitis, rash, pretibial erythematous lesions
Hepatic and renal involvement

Four clinical patterns:

Mild influenza-like illness (most common)
Weil syndrome - the classic severe form: jaundice + acute kidney injury (AKI) + hemorrhage + myocarditis with arrhythmias
Meningitis / meningoencephalitis
Pulmonary hemorrhage with respiratory failure (high mortality)

Severe disease features (up to 10% of patients, mortality 5-15%):

Non-oliguric AKI (acute tubulointerstitial nephritis)
Marked hyperbilirubinemia (>30 mg/dL) with only mild aminotransferase elevation
Thrombocytopenia
Pulmonary involvement
Proximal tubular dysfunction (electrolyte wasting, glycosuria, phosphaturia)
Rhabdomyolysis
Brenner & Rector's The Kidney, p. 757-758

Diagnosis

Microscopic agglutination test (MAT) - gold standard serological test
Blood/urine culture (leptospires grow slowly in special media)
PCR - useful in early leptospiremic phase
Serology: IgM ELISA (LEPTO Dipstick)
Often misdiagnosed as dengue, malaria, or influenza in endemic areas

Treatment

Severity	Drug of choice
Mild disease	Oral doxycycline 100 mg twice daily x 7 days
Severe disease	IV penicillin G or IV ceftriaxone 1 g daily x 7 days
Prophylaxis (occupational)	Doxycycline 200 mg weekly

Early antibiotic treatment shortens duration. In the immune phase, antibiotics are less effective as bacterial clearance has largely occurred.

Prevention

Avoid contact with potentially contaminated water/soil
Protective footwear and clothing in high-risk occupations
Rodent control
Vaccines available for animals; human vaccines used in some endemic countries (Cuba, China, Japan)

Recent evidence: A 2025 Nature Reviews Disease Primers review (PMID: 40316520) reaffirms leptospirosis as a major neglected tropical disease and highlights its growing burden in the context of climate change and urban flooding. It remains frequently underdiagnosed globally.

Brief information for 1.Malaria 2.dengue 3.typhoid

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have enough information from all three sources to compile comprehensive briefs. Here they are:

1. MALARIA

Definition & Causative Agent

Malaria is caused by protozoan parasites of the genus Plasmodium, transmitted by bites of infected female Anopheles mosquitoes. Four main species infect humans:

Species	Fever Cycle	Notes
P. falciparum	48 hrs	Most dangerous; causes severe disease
P. vivax	48 hrs	Hypnozoites - can relapse
P. ovale	48 hrs	Hypnozoites - can relapse
P. malariae	72 hrs (quartan)	Associated with nephrotic syndrome
P. knowlesi	24 hrs	Zoonotic; Southeast Asia

Goldman-Cecil Medicine, p. 3391-3393

Epidemiology

Most important parasitic disease of humans - hundreds of millions of illnesses and hundreds of thousands of deaths annually
Predominantly in sub-Saharan Africa, South/Southeast Asia, Latin America
Female Anopheles mosquitoes bite at night
High-risk groups: young children, pregnant women, non-immune travellers

Life Cycle & Pathogenesis

Mosquito injects sporozoites → travel to liver → infect hepatocytes (asymptomatic)
Liver releases merozoites → invade red blood cells
Asexual erythrocytic cycles cause RBC destruction → fever, anemia, hemolysis
P. vivax and P. ovale can persist as dormant hypnozoites in the liver → relapses
Some parasites develop into gametocytes → ingested by mosquitoes → sexual reproduction

Clinical Features

Incubation: 7-14 days (P. falciparum); up to months for others

Uncomplicated malaria:

Classic triad: fever, chills, rigors (paroxysmal, cyclic)
Headache, myalgia, fatigue, nausea/vomiting
Splenomegaly with repeated infections

Severe malaria (mainly P. falciparum):

Cerebral malaria - altered consciousness, seizures, coma (most common severe complication in children)
Severe anemia
Acute renal failure (adults > children)
Non-cardiogenic pulmonary edema
Blackwater fever - intravascular hemolysis + hemoglobinuria
Hypoglycemia, metabolic/lactic acidosis
Thrombocytopenia and coagulopathy
Jaundice (hemolysis or hepatic dysfunction)
Splenic rupture

Diagnosis

Thick blood smear with Giemsa stain - gold standard; estimates parasite density
Thin blood smear - species identification
Rapid diagnostic tests (RDTs) - detect P. falciparum HRP2 antigen; fast, easy to use
PCR - most sensitive, used for species confirmation

Treatment

Situation	Treatment
Uncomplicated P. falciparum	Artemisinin-based combination therapy (ACT) (e.g., artemether-lumefantrine)
Chloroquine-sensitive malaria	Chloroquine (non-falciparum or sensitive falciparum)
Severe malaria	IV artesunate (preferred over quinine)
P. vivax/P. ovale (radical cure)	ACT/chloroquine + primaquine (to kill hypnozoites; check G6PD first)
Chemoprophylaxis	Atovaquone-proguanil, doxycycline, or mefloquine

Note: Artemisinin resistance is a growing concern in Southeast Asia.

Prevention

Insecticide-treated bed nets (ITNs)
Indoor residual spraying (IRS)
Chemoprophylaxis for travellers
RTS,S/AS01 vaccine (Mosquirix) - WHO-recommended for children in high-transmission areas

2. DENGUE

Definition & Causative Agent

Dengue is caused by dengue virus (DENV), a flavivirus with 4 serotypes (DENV 1-4). It is transmitted by Aedes mosquitoes (Aedes aegypti primarily, also A. albopictus), which are day-biters adapted to urban environments.

Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 336

Epidemiology

Estimated 400 million infections/year globally; ~100 million symptomatic; ~40,000 deaths
Most prevalent in Southeast Asia, Western Pacific, India, tropical Americas
Spreading due to climate change - Aedes habitat now extends into southern USA, France, Italy, Spain
The most common febrile illness in travellers returning from Southeast Asia

Pathogenesis

Virus infects via mosquito bite → replicates in dendritic cells and macrophages → viremia
Antibody-dependent enhancement (ADE): Cross-reactive antibodies from a prior infection with a different serotype enhance macrophage uptake of the new serotype via Fc receptors → increased viral load → severe dengue
This explains why second infections with a different serotype carry the highest risk of severe disease
Serotype DENV-2 is most commonly associated with severe outcomes

Clinical Features

Incubation: 2-15 days after infectious bite

Classic dengue fever:

Sudden high fever, severe myalgias ("breakbone fever"), headache
Retro-orbital pain
Characteristic skin rash in ~50% - macular/morbilliform, "islands of white in a sea of red," appearing at days 3-5 as fever defervesces
Facial flushing
Labs: thrombocytopenia (<100,000 in 50%), leukopenia, elevated LFTs (~3x normal)
Positive tourniquet test (≥10 petechiae/sq inch)
Recovery in 7-10 days

Severe dengue (DHF/DSS):

Plasma leakage → shock (dengue shock syndrome)
Widespread hemorrhages
Hepatitis, diffuse alveolar damage
Organ failure, reduced consciousness

Diagnosis

NS1 antigen - detectable in first 5 days
IgM/IgG serology - IgM rises after day 5
PCR - gold standard in early illness
CBC showing thrombocytopenia + leukopenia is a strong clue

Treatment

Supportive only - no specific antiviral therapy
Adequate hydration (oral or IV)
Paracetamol for fever - avoid NSAIDs and aspirin (bleeding risk)
Platelet transfusion for severe bleeding
Monitor for plasma leakage warning signs (rapid defervescence + clinical deterioration)

Prevention

Aedes mosquito vector control (remove standing water, larvicides)
Personal protection (repellents, clothing)
Dengvaxia vaccine - approved in some countries but only for previously seropositive individuals (prior infection must be confirmed)

3. TYPHOID FEVER

Definition & Causative Agent

Typhoid fever is a systemic febrile illness caused by Salmonella enterica serotype Typhi (S. typhi). Paratyphoid fever is caused by S. paratyphi A, B, or C. Humans are the only natural reservoir for S. typhi.

Sleisenger & Fordtran's GI and Liver Disease, p. 2197

Epidemiology

Endemic in areas with poor sanitation and unsafe water - Africa, Southeast Asia, South Asia, Western Pacific
~400 travellers returning to the USA are diagnosed annually
Once malaria is excluded, typhoid is the most common cause of febrile illness lasting >10 days
Typhoid fever killed more soldiers throughout history than combat injuries

Transmission & Pathogenesis

Fecal-oral route - contaminated food or water; dose-dependent transmission
Carriers (chronic) shed S. typhi in feces and urine without symptoms
Organism invades the Peyer's patches of the ileum → bacteremia → systemic spread to liver, spleen, bone marrow
Main pathology: inflammation, necrosis, and ulceration of the intestinal wall

Clinical Features

Incubation: 1-3 weeks

Week 1: Gradual-onset fever, headache, dry cough, malaise Week 2-3: High fever (stepladder pattern), chills, severe headache, relative bradycardia (pulse-temperature dissociation), abdominal distention, myalgias

Key signs:

Rose spots - pale red macular rash on trunk (in fair-skinned individuals)
Splenomegaly
Relative bradycardia (classic but may be absent)
Constipation (30%) or diarrhea

Labs: leukopenia, elevated liver enzymes (non-specific)

Complications:

Intestinal perforation (most feared)
GI hemorrhage
Anemia, DIC, mycotic aneurysm
Pneumonia, meningitis, myocarditis, cholecystitis, renal failure
Neurological sequelae: deafness, psychosis, ataxia, seizures

Untreated mortality: 10-20% (mainly in young children)

Diagnosis

Blood culture (most sensitive in Week 1)
Urine/stool culture (Week 2 onward)
Bone marrow culture - most sensitive overall; positive even after antibiotics
Widal test (serology) - less reliable
Rapid antigen tests available in endemic settings

Treatment

Severity	Preferred Drug
Uncomplicated	Ciprofloxacin 500 mg BD x 7-10 days OR ceftriaxone 2 g IV x 10-14 days
Fluoroquinolone-resistant	Azithromycin 1 g daily x 5 days
Severe (meningitis/shock)	IV ceftriaxone + dexamethasone

Note: Fluoroquinolone resistance is rising, especially in travellers from South and Southeast Asia
Chloramphenicol, ampicillin, and TMP-SMX are unreliable due to resistance

Prevention

Safe water and sanitation
Typhoid vaccine (oral Ty21a or injectable Vi capsular polysaccharide) - recommended for travellers; protection wanes over time, revaccination required
Relapses can occur after clinical improvement

Quick Comparison Table

Feature	Malaria	Dengue	Typhoid
Causative agent	Plasmodium spp. (protozoa)	Dengue virus (flavivirus)	Salmonella typhi (bacteria)
Vector/Route	Anopheles mosquito (night)	Aedes mosquito (day)	Fecal-oral
Incubation	7-14 days (up to months)	2-15 days	1-3 weeks
Fever pattern	Cyclical/paroxysmal	Sudden high, defervesces day 3-5	Stepladder (gradual rise)
Classic sign	Splenomegaly, anemia	"Islands of white in sea of red" rash	Rose spots, relative bradycardia
Key lab finding	Parasites on blood smear	Thrombocytopenia + leukopenia	Leukopenia
Diagnosis	Thick blood smear / RDT	NS1 antigen / serology	Blood culture
Treatment	ACT (artemisinin-based)	Supportive only	Ciprofloxacin / Ceftriaxone
Vaccine available	Yes (RTS,S)	Yes (Dengvaxia - selected pts)	Yes (oral/injectable)

This is a shared conversation. Sign in to Orris to start your own chat.